Condensed Statements of Shareholders' Deficiency (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	$ (980,017)	$ (877,916)	$ (931,279)	$ (835,587)
Net loss	(22,799)	(21,854)	(71,537)	(64,183)
Ending balance	$ (1,002,816)	$ (899,770)	$ (1,002,816)	$ (899,770)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance (in shares)	1,899,575	1,899,575	1,899,575	1,899,575
Beginning balance	$ 1,900	$ 1,900	$ 1,900	$ 1,900
Ending balance (in shares)	1,899,575	1,899,575	1,899,575	1,899,575
Ending balance	$ 1,900	$ 1,900	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	8,418,684	8,418,684	8,418,684	8,418,684
Ending balance	8,418,684	8,418,684	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	(9,400,601)	(9,298,500)	(9,351,863)	(9,256,171)
Net loss	(22,799)	(21,854)	(71,537)	(64,183)
Ending balance	$ (9,423,400)	$ (9,320,354)	$ (9,423,400)	$ (9,320,354)